成本共享与类风湿性关节炎疾病负担的关联
Sharon Dowell1, Christopher J Swearingen2, Manuela Pedra-Nobre3
1Howard University College of Medicine, Washington, DC.
ACR open rheumatology
|June 19, 2023
概括
成本共享影响了类风湿性关节炎 (RA) 疾病负担,在美国南部观察到更高的负担. 政府的保险计划可能需要更多的支持,以高疾病活动的RA患者.
科学领域:
- 类风湿病学 类风湿病学
- 卫生经济学 卫生经济学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 类风湿性关节炎 (RA) 管理涉及患者的重大成本共享,包括办公室访问 (OV) 和药物共付.
- 医疗保健和保险覆盖的区域差异可能会影响整个美国的RA疾病负担.
研究的目的:
- 调查美国风湿性关节炎 (RA) 患者的成本共享的地理差异.
- 确定成本共享,保险类型和RA疾病负担之间的关联,用风湿性疾病共发症指数 (RDCI) 来衡量.
主要方法:
- 分析了来自美国东北部,南部和西部的风湿病诊所的402名RA患者.
- 收集的数据包括社会人口统计,RA疾病状况,并发症 (RDCI得分),初级保险类型以及OV和药物的共同支付成本.
- 统计分析包括单变量对差异和多变量回归模型来评估关联.
主要成果:
- 美国南部的患者表现出更高的疾病活性和RDCI得分,更频繁的OV共付超过25美元.
- 较低的共同支付 (OVs<10美元,药物<25美元) 与显著更高的RDCI有关,独立于地区或种族.
- 与那些接受医疗保险或医疗补助的人相比,私人保险人员的RDCI较低,不论地理区域或种族.
结论:
- 成本共享政策可能会阻碍RA患者的最佳护理,特别是在美国南部地区.
- 政府赞助的保险计划可能需要加强支持,以充分覆盖患有高疾病负担的RA患者.
相关概念视频
01:11Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
01:23Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
01:21Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
01:20Rheumatic Heart Disease IV: Nursing Management
23
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
23
01:20The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K